1. Long noncoding RNAs in cancer cells
    Duc-Hiep Bach et al, 2018, Cancer Letters CrossRef
  2. LncRNA LINC01446 promotes glioblastoma progression by modulating miR-489-3p/TPT1 axis
    Li Zhang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  3. Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma
    Lei Qin et al, 2018, J Cell Biochem CrossRef
  4. Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics
    Sotirios P. Fortis et al, 2018, Cancer Immunol Immunother CrossRef
  5. Colon Cancer-Associated Transcripts 1 and 2 : Roles and functions in human cancers
    Soudeh Ghafouri-Fard et al, 2019, J Cell Physiol CrossRef
  6. Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer
    Liuhong Zheng et al, 2019, Biosci. Rep. CrossRef
  7. Long Noncoding RNA Expression Signatures of Colon Cancer Based on the ceRNA Network and Their Prognostic Value
    Yang Cheng et al, 2019, Disease Markers CrossRef
  8. CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer
    Ke Wang et al, 2019, J Cell Biochem CrossRef
  9. Analysis of long non-coding RNAs in neonatal piglets at different stages of porcine deltacoronavirus infection
    Xiaoyu Tang et al, 2019, BMC Vet Res CrossRef
  10. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
    Weijia Li et al, 2020, J Cell Physiol CrossRef
  11. LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway.
    Guoqing Li et al, 2019, J Cell Mol Med CrossRef
  12. LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway
    Wei Zong et al, 2019, Gastric Cancer CrossRef
  13. Integrated Analysis of mRNA–miRNA–lncRNA ceRNA Network in Human HR+/Her-2− Breast Cancer and Triple Negative Breast Cancer
    Xiaochen Jia et al, 2019, Journal of Computational Biology CrossRef
  14. Construction of competing endogenous RNA networks from paired RNA-seq data sets by pointwise mutual information
    Chaowang Lan et al, 2019, BMC Genomics CrossRef
  15. HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1
    Shengcai Chen et al, 2019, Cancer Cell Int CrossRef
  16. LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer
    Xiaohua Li et al, 2020, J Biosci CrossRef
  17. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p
    Qiang Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  18. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”
    Katia Grillone et al, 2020, J Exp Clin Cancer Res CrossRef
  19. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
    Huaiguo Wu et al, 2020, J Cell Mol Med CrossRef
  20. Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma
    Chengjie Lin et al, 2018, Mol Med Report CrossRef
  21. LOC134466 methylation promotes oncogenesis of endometrial carcinoma through LOC134466/hsa-miR-196a-5p/TAC1 axis.
    Hai Xu et al, 0 CrossRef
  22. Long-noncoding RNA LINC00461 promotes proliferation and invasion of nonsmall cell lung cancer cells via targeting miR-518a-3p/WDR1 pathway
    Zuopei Wang et al, 2020, Journal of Receptors and Signal Transduction CrossRef
  23. LncRNA PVT1 Acts as a Tumor Promoter in Thyroid Cancer and Promotes Tumor Progression by Mediating miR-423-5p-PAK3
    Qiu-Yu Lin et al, 2020, CMAR CrossRef
  24. Decreased expression level of long non-coding RNA CCAT1, was observed in breast cancer tissue of an Isfahanian population (Iran)
    Mansoureh Azadeh et al, 2021, Gene Reports CrossRef
  25. Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression
    Sheng Gao et al, 2021, Front. Genet. CrossRef
  26. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior
    Rubén Rodríguez-Bautista et al, 2021, Cancers CrossRef
  27. What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1)
    Noha A. Selem et al, 2021, Non-coding RNA Research CrossRef
  28. Bioinformatics Approach for Data Capturing: The Case of Breast Cancer
    Ramji Gupta et al, 2021, CCTR CrossRef
  29. The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients
    Yujiao Yu et al, 2022, Mol Neurobiol CrossRef
  30. Long non-coding RNA PVT1 facilitates cell migration and invasion by regulating miR-148a-3p and ROCK1 in breast cancer
    H.L Li et al, 2022, Clin Transl Oncol CrossRef
  31. Network Approaches for Charting the Transcriptomic and Epigenetic Landscape of the Developmental Origins of Health and Disease
    Salvo Danilo Lombardo et al, 2022, Genes CrossRef
  32. Identification of a novel lncRNA‐miRNA‐mRNA competing endogenous RNA network associated with prognosis of breast cancer
    Xiaohui Wan et al, 2022, J Biochem & Molecular Tox CrossRef
  33. Somatic point mutations are enriched in non-coding RNAs with possible regulatory function in breast cancer
    Narges Rezaie et al, 2022, Commun Biol CrossRef
  34. Innovative targets of the lncRNA-miR-mRNA network in response to low-dose aspirin in breast cancer patients
    Sadaf Alipour et al, 2022, Sci Rep CrossRef
  35. Transcriptome Sequencing Analysis of the Effect of β-Elemene on Colorectal Cancer from the lncRNA-miRNA-mRNA Perspective
    Heng Deng et al, 2022, Genetics Research CrossRef
  36. Comprehensive Characterization of Immune Landscape Based on Tumor Microenvironment for Oral Squamous Cell Carcinoma Prognosis
    Qi-Lin Li et al, 2022, Vaccines CrossRef
  37. Particulate Matters Affecting lncRNA Dysregulation and Glioblastoma Invasiveness: In Silico Applications and Current Insights
    Swagatama Mukherjee et al, 2022, J Mol Neurosci CrossRef
  38. RNA-Interference-Mediated miR-122-Based Gene Regulation in Colon Cancer, a Structural In Silico Analysis
    Harsha Ganesan et al, 2022, IJMS CrossRef
  39. Cytokine, chemokine alterations and immune cell infiltration in Radiation-induced lung injury: Implications for prevention and management
    Haochun Guo et al, 2024, International Immunopharmacology CrossRef
  40. LINC01140 Hinders the Development of Breast Cancer Through Targeting miR-200b-3p to Downregulate DMD
    Gongling Peng et al, 2023, Cell Transplant CrossRef
  41. Transcription Analysis of the THBS2 Gene through Regulation by Potential Noncoding Diagnostic Biomarkers and Oncogenes of Gastric Cancer in the ECM-Receptor Interaction Signaling Pathway: Integrated System Biology and Experimental Investigation
    Ali Barani et al, 2023, International Journal of Genomics CrossRef
  42. MALAT-1 Is a Key Regulator of Epithelial–Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis
    Mohamed Ali Hussein et al, 2024, Cancers CrossRef
  43. Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer
    Ahmed Saeed Abd ELhafeez et al, 2023, CBM CrossRef
  44. Differential expression of Nickel nanoparticles of Lactobacillus plantarum on VDR/LncRNA EIF3J-DT in Colorectal Cancer
    Saradhadevi Muthukrishnan et al, 2024, Medicine in Omics CrossRef
  45. In silico identification and in vitro evaluation of MRPS30‐DT lncRNA and MRPS30 gene expression in breast cancer
    Nooshafarin Shirani et al, 2024, Cancer Reports CrossRef